InsidersTradesSigma
Track the LifeStance Health Group, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, LifeStance Health Group, Inc. has published 52 insider filings. Market capitalisation: €4.7bn. The latest transaction was disclosed on 14 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Bessler Robert. All data is accessible without an account.
52
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€487m
35 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate LifeStance Health Group, Inc. Buy (bullish), based on 10 analysts. Average price target: US$13.80.
48Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,802 of 29,063 companies
37.2
score / 100
Value43
Quality32
FCF yld2.3%
Earn yld0.2%
EV/EBITDA·
ROE3.4%
Gross mgn32%
Net mgn0.7%
Debt/EBITDA6.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 August 2026
Declarations52 total
7,500 shares@ US$12.68250.0020% mcap27.5% of flowCommonSEC144:0001959173-26-006038
20,441 shares@ US$12.23Common StockSEC:0001193125-26-352699:0
20,441 shares@ US$12.230.0054% mcap100.0% of flowCommonSEC144:0001959173-26-005973
447,168 sharesCommon StockSEC:0001193125-26-290752:0
447,169 sharesCommon StockSEC:0001193125-26-290752:1
28,281,943 shares@ US$8.024.78% mcap100.0% of flowCommon StockSEC:0001999371-26-010737:0
287,517 shares@ US$8.020.049% mcap50.0% of flowCommon StockSEC:0001193125-26-224379:0
243,362 shares@ US$8.020.041% mcap50.0% of flowCommon StockSEC:0001193125-26-224378:0
5,899,661 shares@ US$8.021.00% mcap35.6% of flowCommon StockSEC:0001193125-26-224376:0
3,876 shares@ US$7.000.0006% mcap0.5% of flowCommon StockSEC:0001193125-26-182153:1
3,876 shares@ US$7.000.0006% mcap0.5% of flowCommon StockSEC:0001193125-26-182153:0
31,073 shares@ US$7.050.0050% mcap4.3% of flowCommon StockSEC:0001193125-26-182153:2
31,074 shares@ US$7.050.0050% mcap4.3% of flowCommon StockSEC:0001193125-26-182153:3
2,551 shares@ US$7.010.0004% mcap0.3% of flowCommon StockSEC:0001193125-26-173787:0
2,550 shares@ US$7.010.0004% mcap0.3% of flowCommon StockSEC:0001193125-26-173787:1
9,376 shares@ US$6.3715.1% of flowCommon StockSEC:0001193125-26-142498:0
10,000 shares@ US$7.320.0017% mcap15.4% of flowCommon StockSEC:0000899243-22-023602:0
5,000 shares@ US$7.327.7% of flowCommon StockSEC:0000899243-22-023093:0
78,858 shares@ US$5.3046.8% of flowCommon StockSEC:0000899243-22-022399:0
3,463 shares@ US$5.34100.0% of flowCommon StockSEC:0000899243-22-022403:0
2,638 shares@ US$5.33100.0% of flowCommon StockSEC:0000899243-22-022394:0
56,370 shares@ US$5.3584.9% of flowCommon StockSEC:0000899243-22-022402:0
328,615 shares@ US$5.33100.0% of flowCommon StockSEC:0000899243-22-022393:0
85,879 shares@ US$5.32100.0% of flowCommon StockSEC:0000899243-22-022401:0
67,479 shares@ US$5.3276.9% of flowCommon StockSEC:0000899243-22-022392:0
25 of 52 declarations
关于 LifeStance Health Group, Inc.
LifeStance Health Group, Inc. 是一家美国门诊心理健康服务提供商，在纳斯达克（美国）上市，股票代码为 LFST。该公司成立于 2017 年，旨在打造一个由技术赋能的行为健康平台，以扩大医疗服务的可及性、提高可负担性并提供更个性化的治疗效果。其总部位于亚利桑那州斯科茨代尔，业务遍及全国，在 33 个州设有 550 多个中心。([investor.lifestance.com](https://investor.lifestance.com/?utm_source=openai)) LifeStance 汇集了精神科医生、心理学家、高级执业护士和治疗师，为儿童、青少年和成人提供综合心理保健服务。其服务范围包括心理治疗、药物管理、测试和评估、女性服务、专科治疗以及焦虑症、抑郁症和成瘾等疾病的护理。该公司通过结合面对面诊所和远程医疗能力的混合模式运营，使其能够将临床邻近性与数字化便利性相结合。([lifestance.com](https://lifestance.com/about-us/?utm_source=openai)) 从竞争角度来看，LifeStance 凭借其地理规模、广泛的临床医生基础和混合式医疗服务模式，跻身美国最大的门诊心理健康平台之列。根据其 2024 年年度报告，截至 2024 年 12 月 31 日，该公司在 33 个州雇佣了 7,424 名临床医生，并在 2024 年期间为超过 940,000 名独特患者提供了约 7.9 million 次就诊。在高度分散的市场中，行为健康服务的需求结构性强劲，这种规模至关重要。([sec.gov](https://www.sec.gov/Archives/edgar/data/1845257/000095017025029100/lfst-20241231.htm?utm_source=openai)) 近期发展表明运营势头正在改善，资本配置状况也更加严谨。在 2025 年第四季度和全年业绩中，LifeStance 报告了收入和调整后 EBITDA 的增长，并预计 2026 年收入将达到 1.615 billion 美元至 1.655 billion 美元，同时授权了一项高达 100 million 美元的股票回购计划。对于投资者而言，这种组合表明公司更加注重现金生成、利润扩张和资产负债表效率。([investor.lifestance.com](https://investor.lifestance.com/news-releases/news-release-details/lifestance-reports-fourth-quarter-and-full-year-2025-results/?utm_source=openai)) 从战略上讲，LifeStance 的吸引力在于其庞大的美国业务版图、对高发心理健康状况的关注以及通过实体中心和虚拟渠道提供护理的能力。该公司仍面临典型的行业风险，包括报销压力、临床医生招聘和留用、监管、网络安全和竞争。对于法语投资者而言，LFST 可被视为一家以增长为导向的医疗保健公司，具有有利的长期需求背景，但其仍严重依赖执行力和运营可扩展性。([nasdaq.com](https://www.nasdaq.com/press-release/lifestance-reports-fourth-quarter-and-full-year-2025-results-2026-02-25?utm_source=openai))
